Clinical trial
Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)
NCT02975050 · Zoll Medical Corporation, Industry · Completed
Key facts
| NCT number | NCT02975050 |
|---|---|
| Title | Vital Signs Validation Study of the μ-Cor System (ViVUS Validation) |
| Official title | Vital Signs Validation Study of the μ-Cor System (ViVUS Validation) |
| Acronym | ViVUS |
| Lead sponsor | Zoll Medical Corporation, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Health Volunteer Validation Study |
| Intervention type | Other |
| Interventions | Location |
| Enrollment | 30 |
| Start date | Nov 28, 2016 |
| Primary completion | Jan 19, 2017 |
| Completion | Jan 19, 2017 |
| First posted | Nov 29, 2016 |
| Last update posted | Jul 7, 2020 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: